This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Organ Preservation Market

Market Insights on Organ Preservation covering sales outlook, demand forecast & up-to-date key trends

Organ Preservation Market by Solution (University of Wisconsin Solution, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermia Machine Perfusion, and Normothermic Machine Perfusion), Organ Type (Kidney, Liver, Lung, Heart, Pancreas), End User (Organ Transplant Centres, Hospitals, Speciality Clinics) & Region - Forecast 2022 - 2032

Organ Preservation Market (2022-2032)

[323 Pages Report] Global organ preservation market value is estimated to reach US$ 455 Million by 2032, with a compound annual growth rate of 6.4%.

  • Growing demand for organ transplants and organ failures is expected to drive the market
  • A growing number of diseases is expected to propel market growth for the organ preservation market
  • Investments in healthcare will promote organ preservation growth.
  • Kidney transplant rates will rise due to increased cases of kidney failure and chronic kidney disease.

The process of preserving healthy organs from a donor so that they can be transplanted into the body of a recipient is called organ preservation. Static cold storage (SCS) aids in maintaining normal organ function after transplantation by preventing harmful metabolites from degrading healthy tissue.

Those suffering from terminal diseases are the most likely to benefit from organ transplantation. Preservation solutions and techniques are essential to preserving organ quality and preventing transplant-associated death and morbidity. In most cases, static cold storage (SCS) is considered to be the most efficient and effective method of preserving and transporting organs due to its simplicity and effectiveness.

Over the past few decades, solid organ transplants have been one of the most significant medical advancements. A wide variety of methods for preserving organs have been applied during cold storage to reduce ischemic and hypoxic injury and increase graft survival.

Since the advent of clinical organ transplants 50 years ago, patient and graft survival rates have surpassed 90% per year, resulting in organ transplantation becoming the treatment of choice for end-stage organ disease patients.

Attributes

Details

Organ Preservation Market CAGR (2022-2032)

6.4%

Organ Preservation Market (2026)

US$ 317 Mn

Organ Preservation Market Attraction

Rising proportion of geriatric population in North America and European countries will be the major driver for the growth of global organ preservation market during the forecasted years.

Customize this Report

Let us know your requirement to get
100% FREE customization

Growth Prospects of Organ Preservation in the Asia Pacific Region

With the largest population seeking better treatments, including organ transplantation preservation, the Asia Pacific region is expected to be the fastest-growing region as a whole in the industry. Asian countries are seeing an increase in awareness about organ donation, which has led to a rise in the market for organ preservation solutions.

Developing nations such as India and China are experiencing an increase in the eye, cardiac, and kidney diseases. Technology advancement and emerging markets will offer profitable opportunities for the market. The government has also taken several initiatives to promote organ donation as part of its efforts to further expand the market growth. For instance,

Organ donation and transplantation are promoted by the Indian government through its National Organ Transplant Programme (NOTP). Several regional and state organ and tissue transplant organizations have been established under this initiative: one at the highest level in New Delhi, five at the regional level, and sixteen at the state level.

Additionally, the National Organ Transplant Programme provides financial assistance to States for the establishment of Biomaterial Centers. Various IEC activities are being organized to raise public awareness and impart training to physicians and transplant coordinators to facilitate the acceptance of transplants.

Future Research Trends in Organ Preservation Markets

With targeted radiotherapy and chemotherapy, medical professionals aim to preserve a surgically removed organ by preventing the particular cell from multiplying as a result of targeting radiotherapy and chemotherapy. As part of UICC's Access to Oncology Medicines (ATOM) initiative, multiple stakeholders were invited to the table to find ways of making cancer medicines more accessible and affordable especially in India.

An exciting development in health care has been the development of xenotransplantation - the ability to use a genetically modified organ from an animal to be used in humans after genetic modification. As gene editing techniques are developed and new knowledge is gained about the immunology of animals and its differences from the immune system of humans, it will probably continue to be a field that sees many advancements in the near future.

“The geriatric population count is increasing day by day, leading to increased incidents of multi-organ failures and organ transplant surgeries worldwide. The requirement of efficient management of organ transfer from donors is driving the organ preservation market. ”

In 2019, the Health Resources and Services Administration reported about the rise in death cases due to multiple organ failures in the US. The major treatment for such types of patients is organ replacement facilitated by human organ transplantation surgeries.

The organs obtained from donors require the appropriate handling and care achieved through the proper organ storage in cryogenic systems. The companies providing organic preservation solutions to hold and carry the organs from donors to patients have experienced exponential growth these days.

Organ procurement and transplant network have expanded many folds making it easier for patients suffering from organ disorders. Organ preservation chemicals used for the storage of such organs obtained from companies dealing in the medical sector have benefitted immensely in recent years.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Covid-19 Impact on the Global Organ Preservation Market?

Healthcare and medical facilities in all countries were diverted towards the control of the corona infection cases. The other medical services were abruptly halted, negatively impacting the organ preservation and transplantation market.

All the patients requiring the replacement of organs had to undergo rigorous Covid-19 testing and confirmation before getting admitted to any healthcare facilities. Most of the skilled surgeons and healthcare professionals were also engaged in taking care of patients admitted with Covid-19 symptoms.

The problem in obtaining raw materials for the production of organ preservation solutions in the manufacturing units had some serious impact on the supply of preserved organs over long distances.

Restrictions on transportation and logistics were another major problem hampering the transport of human organs preserved for donation. In post-pandemic years demand for organ preservation and transplantation services increased due to serious effects of the coronavirus on the internal organs of the body.

What are the Dynamics in the Organ Preservation Market?

“Diabetes and Chronic diseases have increased in frequency in the recent past resulting in severe medical conditions for multiple organ failures. Cardiovascular disorders and obesity have escalated the condition of patients to undertake replacement of organs providing a huge impetus for the growth of organ preservation market across the globe.”

Solid-Organ transplant procedures have become more successful and safer in the 21st century owing to considerable advancement in surgical procedures and knowledge about the function of different organs.

But the healthcare sector is still struggling to meet the demands for organ transplantation due to the unavailability of sufficient organ donors or limited supply of organ preservation fluids required to store and transport the organs already donated.

What are the Recent Developments providing Better Opportunities for the Growth of Organ Preservation Market?

Over the past years, there have been some major advancements in medical science, particularly in the field of organ preservation techniques and transplantation procedures, creating a huge demand for organ transplants in the global market. Coupled with the rising burden of diabetes patients, the demand for static cold storage organ preservation requirements during these years.

Encouragement for organ donations by various national and international NGOs has spurred the demand for organ preservation chemicals in the lesser-known regions of the world.

Improving health infrastructure across all countries has resulted in increased cases of patient termination in healthcare and medical facilities. The growing supply of organ preservation solutions in such major institutions has made it easier for the collection and preservation of human organs to be utilized by the organ preservation market.

What are Some of the Major Challenges faced by the Global Organ Preservation Market Players in Different Regions?

The development of cryogenic facilities for the maintenance of organ preservation fluid quality during transportation is a major challenge for the global organ preservation market, particularly in developing countries of the Asia Pacific and the Middle East and Africa (MEA).

The cost incurred during organ transplant surgeries and higher expenditure on inpatient care provided by healthcare facilities has remained the major constraint for the growth of the organ preservation and transplantation market. Patients in low-income countries require low-budget healthcare facilities to contribute more to the organ preservation market.

What are the Limitations in the Adoption of Organ Preservation Techniques in Recent Period?

Availability of skilled personnel or surgery doctors at the healthcare centers is pride predicted to be the major challenge for the growth of the organ preservation and transplantation market during the forecast period at a higher scale.

Availability of suitable donors can be another major hindrance in the development of organ preservation techniques reducing the investment in research and advancement of organ preservation procedures by the government institutions and private firms.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Comparative View of Adjacent Organ Preservation Market

Organ Preservation Market:

Attributes

Organ Preservation Market

CAGR (2022 - 2032)

6.4%

Market Value (2026)

US$ 317 Mn

Growth Factor

Multi-organ failure is becoming more common, and the geriatric population is expanding which is driving the market.

Opportunity

Governments all around the world are working to improve their healthcare infrastructures in order to deliver better services.

Key Trends

The rising number of organ transplants and increased attempts to encourage organ donation are driving market expansion in APAC.

Cardiac Monitoring & Cardiac Rhythm Management Devices Market:

Attributes

Cardiac Monitoring & Cardiac Rhythm Management Devices Market

CAGR (2022 - 2032)

4%

Market Value (2026)

US$ 27.9 Bn

Growth Factor

Increase in the incidence of diseases such as hypertension, diabetes, dyslipidemia, and obesity as a result of lifestyle changes, all of which contribute to the rising prevalence of Cardiovascular Diseases around the world.

Opportunity

Measures to reduce infections caused due to CIEDs present a growing opportunity for the market.

Key Trends

Launch of innovative products and technological advancements is propelling the market forward.

Bio preservation Market

Attributes

Bio preservation Market

CAGR (2022 - 2032)

9.1%

Market Value (2026)

US$ 5.3 Bn

Growth Factor

Biobanking breakthroughs and increased R&D investments.

Opportunity

Emerging economies will provide considerable growth prospects for market participants.

Key Trends

The industry is likely to grow as investments in regenerative medicine research increase. The expensive cost of bio preservation equipment, on the other hand, will limit market expansion.

Organ replacement or transplantation is a complex process requiring a wide range of resources for successful completion. Every step in organ preservation and transplantation requires constant monitoring by skilled personnel and is cost-intensive.

Services provided by the healthcare establishments during the organ preservation time is also an expensive method incurred in the bills of patients. However, the bettering economic conditions and support from the government have set the stage for organ replacement surgeries as a more acceptable choice than before.

Moreover, the ever-advancing technological progress in the field of organ storage has lowered the cost of organ transplantation surgeries than before. In the coming years, the cost is expected to fall down owing to the resources invested by market players for carrying out research and development activities in the direction of new methods for organ preservation for transplantation.

How is the Growth Outlook for the Organ Preservation Market on the basis of Different Segments?

The most adopted technique is the static cold storage organ preservation method, commonly referred to as the gold standard technique of Organ preservation. This technique is very convenient to reduce metabolic activities and increase the self-life of the organs. This technique is popular for lung, heart, pancreas and kidney preservation.

Hypothermia Machine Perfusion and Normothermic Machine Perfusion are some of the other techniques that need some research and technological advancements to compete with the static cold storage technique segment.

Which are the Major Organs Constituting the Different Segments of Global Organ Preservation Market?

By the previous market analysis report, kidney preservation was the segment holding the largest share of the global organ preservation market. The escalating cases of ESRD with kidney transplantation has emerged as the major driver for this segment of the market and is predicted to be leading in the forthcoming years.

The other segment based on organ type having the highest potential of growth is liver preservation during the forecast period of 2022 to 2032. Lung, heart and pancreas preservation are the other segments contributing to the growing trend of organ preservation.

Who are the Prominent End Users of the Global Organ Preservation Market?

By 2021, organ transplant centers were the dominating end users of the organ preservation market providing kidney preservation and liver preservation in different regions of the world. The better healthcare facilities and the increasing success rate has made it a popular choice for patients seeking organ replacement around the world. This segment is expected to remain at the forefront for organ preservation and transplantation during the forecast years.

Hospitals and other end users will also contribute significantly to the global organ preservation market, as per the report of the market analysis.

What is the Prospect of Growth for the Global Organ Preservation Market in Different Geographical Regions?

North America, comprising a higher proportion of the elder population and advanced Healthcare facilities, is poised to remain the most attractive region for organ storage and transplantation services.

In addition to the rising demand for technologically advanced treatment methods, government support and reimbursements have fuelled the market for preserved human organs in recent times.

As per the report provided by the American Heart Association and National Chronic kidney Disease Report, 31% of the total deaths in the US occurred due to cardiovascular disorders in 2014 and in 2017, 15% of US adults were subject to chronic kidney diseases.

Due to rising cases of alcoholic fatty liver diseases, Liver failures have positioned the Europe region as the second-largest market for organ preservation and transplantation, following North America. The healthcare expenditure in European countries has further fuelled the market for lever preservation for transplant facilities.

The prevalence of other serious diseases related to cardiovascular and renal will further supplement the demand for organ transplantation surgeries in this region.

Asia Pacific region is predicted to be the fastest-growing region for having the largest population count seeking better treatment methods, including organ transplantation preservation

services. The rising awareness about organ donations has boosted the organ preservation solution market in Asian countries.

Lack of awareness and affordability constraints for organ preservation techniques could render the Middle East and African countries the least attractive region for the global organ preservation market in coming years.

How is the Competitive Landscape for different Key Players of the Global Organ Preservation Market?

The key players in the organ preservation driving the global market are XVIVO Perfusion AB, Dr Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Trans Medics, Organ Ox Limited, Shanghai Genext Medical Technology, Bridge to Life Limited, Waters Medical Systems, Preservation Solutions, Carnamedica, and Transplant Biomedicals.

All the prominent players dealing in organ preservation have continually adopted the advancing technologies and have changed the course of organ preservation from the past to the future to provide the best service for the patients in need.

In recent years they have been focusing on mergers and collaboration to expand the customer base in traditionally less popular regions.

Some of the Recent Developments in Organ Preservation Market:

  • Paragonix Technologies of the US expanded its product offerings in the United States and Europe to strengthen its geographic presence by launching a LIVERgaurd Donor Liver Preservation System in 2021.
  • To gain access to transplantation networks in Latin America in 2021, XVIVO perfusion of Sweden partnered with Contatti Medical of Brazil.
  • Institute Georges Lopez (IgI) of France set up a manufacturing facility in Tamil Nadu, India, in 2021 for expanding its business in medical devices and organ preservation solutions required for flushing and preservation of organs.
  • OCS Heart System prepared by Transmedics company of USA received premedical approval from Food and Drug Administration (FDA) in 2021 for use with organs obtained from donors after brain death (DBD).
  • For distribution and marketing of custodial HTK solutions in the Chinese and Asia Pacific market Dr. Franz Köhler Chemie GmbH, Melchers Group and CICEL of Germany started a joint venture in 2020 by the name of Köhler Pharmaceuticals at Beijing.

Key Segments

By Solution:

  • University of Wisconsin Solution (UW Solution)
  • Custodial HTK
  • Perfadex
  • Other Solutions

By Technique:

  • Static Cold Storage
  • Hypothermia Machine Perfusion
  • Normothermic Machine Perfusion

By Organ Type:

  • Kidney
  • Liver
  • Long
  • Heart
  • Pancreas

By End User:

  • Organ Transplant Centres
  • Hospitals
  • Speciality Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global organ preservation market is predicted to register a CAGR of 6.4% during the forecast period.

The global organ preservation market was valued at US$ 230 Mn in 2021.

The global organ preservation market is predicted to become a US$ 317 Mn market by the year 2026.

The total market value of organ preservation market is estimated to reach a value of about US$ 455 Mn by the end of 2032.

North America is the dominant region that captured major share of the global organ transplant preservation market and is predicted to remain in the leading position for some more years ahead.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage

    2.2. Market Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Market

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. Market, by Key Countries

    4.2. MarketOpportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Market Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. MarketOpportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Solution

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Solution , 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Solution , 2022-2032

        8.3.1. University of Wisconsin Solution (UW Solution)

        8.3.2. Custodial HTK

        8.3.3. Perfadex

        8.3.4. Other Solutions

    8.4. Market Attractiveness Analysis By Solution

9. Global MarketAnalysis 2015-2021 and Forecast 2022-2032, By Technique

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Technique , 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique , 2022-2032

        9.3.1. Static Cold Storage

        9.3.2. Hypothermic Machine Perfusion

        9.3.3. Normothermic Machine Perfusion

    9.4. Market Attractiveness Analysis By Technique

10. Global MarketAnalysis 2015-2021 and Forecast 2022-2032, By Organ Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Organ Type , 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Organ Type , 2022-2032

        10.3.1. Kidney

        10.3.2. Liver

        10.3.3. Lung

        10.3.4. Heart

        10.3.5. Pancreas

    10.4. Market Attractiveness Analysis By Organ Type

11. Global MarketAnalysis 2015-2021 and Forecast 2022-2032, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By End User , 2015-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2032

        11.3.1. Organ Transplant Centers

        11.3.2. Hospitals

        11.3.3. Specialty Clinics

    11.4. Market Attractiveness Analysis By End User

12. Global MarketAnalysis 2015-2021 and Forecast 2022-2032, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Asia Pacific

        12.3.5. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America MarketAnalysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. U.S.

            13.4.1.2. Canada

            13.4.1.3. Rest of North America

        13.4.2. By Solution

        13.4.3. By Technique

        13.4.4. By End User

        13.4.5. By Organ Type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Solution

        13.5.3. By Technique

        13.5.4. By End User

        13.5.5. By Organ Type

14. Latin America MarketAnalysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Brazil

            14.4.1.2. Mexico

            14.4.1.3. Rest of Latin America

        14.4.2. By Solution

        14.4.3. By Technique

        14.4.4. By End User

        14.4.5. By Organ Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Solution

        14.5.3. By Technique

        14.5.4. By End User

        14.5.5. By Organ Type

15. Europe MarketAnalysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. Germany

            15.4.1.2. France

            15.4.1.3. U.K.

            15.4.1.4. Italy

            15.4.1.5. Benelux

            15.4.1.6. Nordic Countries

            15.4.1.7. Rest of Europe

        15.4.2. By Solution

        15.4.3. By Technique

        15.4.4. By End User

        15.4.5. By Organ Type

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Solution

        15.5.3. By Technique

        15.5.4. By End User

        15.5.5. By Organ Type

16. Asia Pacific MarketAnalysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. China

            16.4.1.2. Japan

            16.4.1.3. South Korea

            16.4.1.4. Rest of Asia Pacific

        16.4.2. By Solution

        16.4.3. By Technique

        16.4.4. By End User

        16.4.5. By Organ Type

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Solution

        16.5.3. By Technique

        16.5.4. By End User

        16.5.5. By Organ Type

17. Middle East and Africa MarketAnalysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        17.4.1. By Country

            17.4.1.1. GCC Countries

            17.4.1.2. South Africa

            17.4.1.3. Turkey

            17.4.1.4. Rest of Middle East and Africa

        17.4.2. By Solution

        17.4.3. By Technique

        17.4.4. By End User

        17.4.5. By Organ Type

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Solution

        17.5.3. By Technique

        17.5.4. By End User

        17.5.5. By Organ Type

18. Key Countries MarketAnalysis 2015-2021 and Forecast 2022-2032

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. US MarketAnalysis

        18.2.1. Value Proportion Analysis by Market Taxonomy

        18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.2.2.1. By Solution

            18.2.2.2. By Technique

            18.2.2.3. By End User

            18.2.2.4. By Organ Type

    18.3. Canada MarketAnalysis

        18.3.1. Value Proportion Analysis by Market Taxonomy

        18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.3.2.1. By Solution

            18.3.2.2. By Technique

            18.3.2.3. By End User

            18.3.2.4. By Organ Type

    18.4. Mexico MarketAnalysis

        18.4.1. Value Proportion Analysis by Market Taxonomy

        18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.4.2.1. By Solution

            18.4.2.2. By Technique

            18.4.2.3. By End User

            18.4.2.4. By Organ Type

    18.5. Brazil MarketAnalysis

        18.5.1. Value Proportion Analysis by Market Taxonomy

        18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.5.2.1. By Solution

            18.5.2.2. By Technique

            18.5.2.3. By End User

            18.5.2.4. By Organ Type

    18.6. Germany MarketAnalysis

        18.6.1. Value Proportion Analysis by Market Taxonomy

        18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.6.2.1. By Solution

            18.6.2.2. By Technique

            18.6.2.3. By End User

            18.6.2.4. By Organ Type

    18.7. France MarketAnalysis

        18.7.1. Value Proportion Analysis by Market Taxonomy

        18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.7.2.1. By Solution

            18.7.2.2. By Technique

            18.7.2.3. By End User

            18.7.2.4. By Organ Type

    18.8. Italy MarketAnalysis

        18.8.1. Value Proportion Analysis by Market Taxonomy

        18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.8.2.1. By Solution

            18.8.2.2. By Technique

            18.8.2.3. By End User

            18.8.2.4. By Organ Type

    18.9. BENELUX MarketAnalysis

        18.9.1. Value Proportion Analysis by Market Taxonomy

        18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.9.2.1. By Solution

            18.9.2.2. By Technique

            18.9.2.3. By End User

            18.9.2.4. By Organ Type

    18.10. UK MarketAnalysis

        18.10.1. Value Proportion Analysis by Market Taxonomy

        18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.10.2.1. By Solution

            18.10.2.2. By Technique

            18.10.2.3. By End User

            18.10.2.4. By Organ Type

    18.11. Nordic Countries MarketAnalysis

        18.11.1. Value Proportion Analysis by Market Taxonomy

        18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.11.2.1. By Solution

            18.11.2.2. By Technique

            18.11.2.3. By End User

            18.11.2.4. By Organ Type

    18.12. China MarketAnalysis

        18.12.1. Value Proportion Analysis by Market Taxonomy

        18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.12.2.1. By Solution

            18.12.2.2. By Technique

            18.12.2.3. By End User

            18.12.2.4. By Organ Type

    18.13. Japan MarketAnalysis

        18.13.1. Value Proportion Analysis by Market Taxonomy

        18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.13.2.1. By Solution

            18.13.2.2. By Technique

            18.13.2.3. By End User

            18.13.2.4. By Organ Type

    18.14. South Korea MarketAnalysis

        18.14.1. Value Proportion Analysis by Market Taxonomy

        18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.14.2.1. By Solution

            18.14.2.2. By Technique

            18.14.2.3. By End User

            18.14.2.4. By Organ Type

    18.15. GCC Countries MarketAnalysis

        18.15.1. Value Proportion Analysis by Market Taxonomy

        18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.15.2.1. By Solution

            18.15.2.2. By Technique

            18.15.2.3. By End User

            18.15.2.4. By Organ Type

    18.16. South Africa MarketAnalysis

        18.16.1. Value Proportion Analysis by Market Taxonomy

        18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.16.2.1. By Solution

            18.16.2.2. By Technique

            18.16.2.3. By End User

            18.16.2.4. By Organ Type

    18.17. Turkey MarketAnalysis

        18.17.1. Value Proportion Analysis by Market Taxonomy

        18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.17.2.1. By Solution

            18.17.2.2. By Technique

            18.17.2.3. By End User

            18.17.2.4. By Organ Type

        18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Product footprint by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. Paragonix Technologies

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Strategy Overview

        20.3.2. XVIVO Perfusion AB

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Strategy Overview

        20.3.3. Dr. Franz Köhler Chemie GmbH

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Strategy Overview

        20.3.4. Essential Pharmaceuticals LLC

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Strategy Overview

        20.3.5. TransMedics

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Strategy Overview

        20.3.6. OrganOx Limited

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Strategy Overview

        20.3.7. Shanghai Genext Medical Technology

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Sales Footprint

            20.3.7.4. Strategy Overview

        20.3.8. Bridge to Life Limited

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Sales Footprint

            20.3.8.4. Strategy Overview

        20.3.9. Waters Medical Systems

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Sales Footprint

            20.3.9.4. Strategy Overview

        20.3.10. Preservation Solutions

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Sales Footprint

            20.3.10.4. Strategy Overview

        20.3.11. Carnamedica

            20.3.11.1. Overview

            20.3.11.2. Product Portfolio

            20.3.11.3. Sales Footprint

            20.3.11.4. Strategy Overview

        20.3.12. Transplant Biomedicals

            20.3.12.1. Overview

            20.3.12.2. Product Portfolio

            20.3.12.3. Sales Footprint

            20.3.12.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn),By Solution , 2015 – 2021

Table 2: Global Market Value (US$ Mn),By Solution , 2022 – 2032

Table 3: Global Market Value (US$ Mn), By Technique , 2015 – 2021

Table 4: Global Market Value (US$ Mn), By Technique , 2022 – 2032

Table 5: Global Market Value (US$ Mn), By Organ Type , 2015 – 2021

Table 6: Global Market Value (US$ Mn), By Organ Type , 2022 – 2032

Table 7: Global Market Value (US$ Mn), By End User , 2015 – 2021

Table 8: Global Market Value (US$ Mn), By End User , 2022 – 2032

Table 9: Global Market , By Region, 2015 – 2021

Table 10: Global Market , By Region, 2022 – 2032

Table 11: North America Market Value (US$ Mn),By Solution , 2015 – 2021

Table 12: North America Market Value (US$ Mn),By Solution , 2022 – 2032

Table 13: North America Market Value (US$ Mn), By Technique , 2015 – 2021

Table 14: North America Market Value (US$ Mn), By Technique , 2022 – 2032

Table 15: North America Market Value (US$ Mn), By Organ Type , 2015 – 2021

Table 16: North America Market Value (US$ Mn), By Organ Type , 2022 – 2032

Table 17: North America Market Value (US$ Mn), By End User , 2015 – 2021

Table 18: North America Market Value (US$ Mn), By End User , 2022 – 2032

Table 19: North America Market , By Country, 2015 – 2021

Table 20: North America Market , By Country, 2022 – 2032

Table 21: Latin America Market Value (US$ Mn),By Solution , 2015 – 2021

Table 22: Latin America Market Value (US$ Mn),By Solution , 2022 – 2032

Table 23: Latin America Market Value (US$ Mn), By Technique , 2015 – 2021

Table 24: Latin America Market Value (US$ Mn), By Technique , 2022 – 2032

Table 25: Latin America Market Value (US$ Mn), By Organ Type , 2015 – 2021

Table 26: Latin America Market Value (US$ Mn), By Organ Type , 2022 – 2032

Table 27: Latin America Market Value (US$ Mn), By End User , 2015 – 2021

Table 28: Latin America Market Value (US$ Mn), By End User , 2022 – 2032

Table 29: Latin America Market , By Country, 2015 – 2021

Table 30: Latin America Market , By Country, 2022 – 2032

Table 31: Europe Market Value (US$ Mn),By Solution , 2015 – 2021

Table 32: Europe Market Value (US$ Mn),By Solution , 2022 – 2032

Table 33: Europe Market Value (US$ Mn), By Technique , 2015 – 2021

Table 34: Europe Market Value (US$ Mn), By Technique , 2022 – 2032

Table 35: Europe Market Value (US$ Mn), By Organ Type , 2015 – 2021

Table 36: Europe Market Value (US$ Mn), By Organ Type , 2022 – 2032

Table 37: Europe Market Value (US$ Mn), By End User , 2015 – 2021

Table 38: Europe Market Value (US$ Mn), By End User , 2022 – 2032

Table 39: Europe Market , By Country, 2015 – 2021

Table 40: Europe Market , By Country, 2022 – 2032

Table 41: Asia Pacific Market Value (US$ Mn),By Solution , 2015 – 2021

Table 42: Asia Pacific Market Value (US$ Mn),By Solution , 2022 – 2032

Table 43: Asia Pacific Market Value (US$ Mn), By Technique , 2015 – 2021

Table 44: Asia Pacific Market Value (US$ Mn), By Technique , 2022 – 2032

Table 45: Asia Pacific Market Value (US$ Mn), By Organ Type , 2015 – 2021

Table 46: Asia Pacific Market Value (US$ Mn), By Organ Type , 2022 – 2032

Table 47: Asia Pacific Market Value (US$ Mn), By End User , 2015 – 2021

Table 48: Asia Pacific Market Value (US$ Mn), By End User , 2022 – 2032

Table 49: Asia Pacific Market , By Country, 2015 – 2021

Table 50: Asia Pacific Market , By Country, 2022 – 2032

Table 51: MEA Market Value (US$ Mn),By Solution , 2015 – 2021

Table 52: MEA Market Value (US$ Mn),By Solution , 2022 – 2032

Table 53: MEA Market Value (US$ Mn), By Technique , 2015 – 2021

Table 54: MEA Market Value (US$ Mn), By Technique , 2022 – 2032

Table 55: MEA Market Value (US$ Mn), By Organ Type , 2015 – 2021

Table 56: MEA Market Value (US$ Mn), By Organ Type , 2022 – 2032

Table 57: MEA Market Value (US$ Mn), By End User , 2015 – 2021

Table 58: MEA Market Value (US$ Mn), By End User , 2022 – 2032

Table 59: MEA Market , By Country, 2015 – 2021

Table 60: MEA Market , By Country, 2022 – 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Market Share, By Solution , 2022 & 2032

Figure 4: Global Market Y-o-Y Growth Projections, By Solution – 2022-2032

Figure 5: Global Market Attractiveness Index, By Solution – 2022-2032

Figure 6: Global Market Share, By Technique , 2022 & 2032

Figure 7: Global Market Y-o-Y Growth Projections, By Technique – 2022-2032

Figure 8: Global Market Attractiveness Index, By Technique – 2022-2032

Figure 9: Global Market Share, By End User , 2022 & 2032

Figure 10: Global Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 11: Global Market Attractiveness Index, By End User – 2022-2032

Figure 12: Global Market Share, By Organ Type , 2022 & 2032

Figure 13: Global Market Y-o-Y Growth Projections, By Organ Type – 2022-2032

Figure 14: Global Market Attractiveness Index, By Organ Type – 2022-2032

Figure 15: Global Market Share, By Region, 2022 & 2032

Figure 16: Global Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 17: Global Market Attractiveness Index, By Region – 2022-2032

Figure 18: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 19: North America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 20: North America Market Share, By Solution , 2022 & 2032

Figure 21: North America Market Y-o-Y Growth Projections, By Solution – 2022-2032

Figure 22: North America Market Attractiveness Index, By Solution – 2022-2032

Figure 23: North America Market Share, By Technique , 2022 & 2032

Figure 24: North America Market Y-o-Y Growth Projections, By Technique – 2022-2032

Figure 25: North America Market Attractiveness Index, By Technique – 2022-2032

Figure 26: North America Market Share, By End User , 2022 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 28: North America Market Attractiveness Index, By End User – 2022-2032

Figure 29: North America Market Share, By Organ Type , 2022 & 2032

Figure 30: North America Market Y-o-Y Growth Projections, By Organ Type – 2022-2032

Figure 31: North America Market Attractiveness Index, By Organ Type – 2022-2032

Figure 32: North America Market Share, By Country, 2022 & 2032

Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 34: North America Market Attractiveness Index, By Country – 2022-2032

Figure 35: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 36: Latin America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 37: Latin America Market Share, By Solution , 2022 & 2032

Figure 38: Latin America Market Y-o-Y Growth Projections, By Solution – 2022-2032

Figure 39: Latin America Market Attractiveness Index, By Solution – 2022-2032

Figure 40: Latin America Market Share, By Technique , 2022 & 2032

Figure 41: Latin America Market Y-o-Y Growth Projections, By Technique – 2022-2032

Figure 42: Latin America Market Attractiveness Index, By Technique – 2022-2032

Figure 43: Latin America Market Share, By End User , 2022 & 2032

Figure 44: Latin America Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 45: Latin America Market Attractiveness Index, By End User – 2022-2032

Figure 46: Latin America Market Share, By Organ Type , 2022 & 2032

Figure 47: Latin America Market Y-o-Y Growth Projections, By Organ Type – 2022-2032

Figure 48: Latin America Market Attractiveness Index, By Organ Type – 2022-2032

Figure 49: Latin America Market Share, By Country, 2022 & 2032

Figure 50: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 51: Latin America Market Attractiveness Index, By Country – 2022-2032

Figure 52: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 53: Europe Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 54: Europe Market Share, By Solution , 2022 & 2032

Figure 55: Europe Market Y-o-Y Growth Projections, By Solution – 2022-2032

Figure 56: Europe Market Attractiveness Index, By Solution – 2022-2032

Figure 57: Europe Market Share, By Technique , 2022 & 2032

Figure 58: Europe Market Y-o-Y Growth Projections, By Technique – 2022-2032

Figure 59: Europe Market Attractiveness Index, By Technique – 2022-2032

Figure 60: Europe Market Share, By End User , 2022 & 2032

Figure 61: Europe Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 62: Europe Market Attractiveness Index, By End User – 2022-2032

Figure 63: Europe Market Share, By Organ Type , 2022 & 2032

Figure 64: Europe Market Y-o-Y Growth Projections, By Organ Type – 2022-2032

Figure 65: Europe Market Attractiveness Index, By Organ Type – 2022-2032

Figure 66: Europe Market Share, By Country, 2022 & 2032

Figure 67: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 68: Europe Market Attractiveness Index, By Country – 2022-2032

Figure 69: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 70: MEA Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 71: MEA Market Share, By Solution , 2022 & 2032

Figure 72: MEA Market Y-o-Y Growth Projections, By Solution – 2022-2032

Figure 73: MEA Market Attractiveness Index, By Solution – 2022-2032

Figure 74: MEA Market Share, By Technique , 2022 & 2032

Figure 75: MEA Market Y-o-Y Growth Projections, By Technique – 2022-2032

Figure 76: MEA Market Attractiveness Index, By Technique – 2022-2032

Figure 77: MEA Market Share, By End User , 2022 & 2032

Figure 78: MEA Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 79: MEA Market Attractiveness Index, By End User – 2022-2032

Figure 80: MEA Market Share, By Organ Type , 2022 & 2032

Figure 81: MEA Market Y-o-Y Growth Projections, By Organ Type – 2022-2032

Figure 82: MEA Market Attractiveness Index, By Organ Type – 2022-2032

Figure 83: MEA Market Share, By Country, 2022 & 2032

Figure 84: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 85: MEA Market Attractiveness Index, By Country – 2022-2032

Figure 86: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 87: Asia Pacific Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 88: Asia Pacific Market Share, By Solution , 2022 & 2032

Figure 89: Asia Pacific Market Y-o-Y Growth Projections, By Solution – 2022-2032

Figure 90: Asia Pacific Market Attractiveness Index, By Solution – 2022-2032

Figure 91: Asia Pacific Market Share, By Technique , 2022 & 2032

Figure 92: Asia Pacific Market Y-o-Y Growth Projections, By Technique – 2022-2032

Figure 93: Asia Pacific Market Attractiveness Index, By Technique – 2022-2032

Figure 94: Asia Pacific Market Share, By End User , 2022 & 2032

Figure 95: Asia Pacific Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 96: Asia Pacific Market Attractiveness Index, By End User – 2022-2032

Figure 97: Asia Pacific Market Share, By Organ Type , 2022 & 2032

Figure 98: Asia Pacific Market Y-o-Y Growth Projections, By Organ Type – 2022-2032

Figure 99: Asia Pacific Market Attractiveness Index, By Organ Type – 2022-2032

Figure 100: Asia Pacific Market Share, By Country, 2022 & 2032

Figure 101: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 102: Asia Pacific Market Attractiveness Index, By Country – 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Organ Transport Devices Market

Published : July 2022

Healthcare

Organ on a Chip Kit Market

Published : June 2018

Healthcare

Organ Function Assays Market

Published : April 2018

Healthcare

Motion Preservation Devices Market

Published : November 2017

Google translate

Organ Preservation Market